Abstract
To clarify the origin of efferent nerves containing renal plexus, the retrograde neuronal tracing was utilized with a new exact closed injection system with microcapsules. The microcapsule was positioned in the rat left renal plexus, and the capsule was filled with fluoro-gold. Retrograde labeled cells were observed in the ipsilateral sympathetic trunk, especially T12 and T13, and the ipsilateral suprarenal ganglia (SrG). There were no labeled cells in the parasympathetic nuclei in medulla oblongata and sacral cords. These results indicated that the origins of efferent nerves in the rat renal plexus are almost all sympathetic ganglia, such as sympathetic trunk and SrG, and cells in other ganglia may be secondary or accessory innervations.
Introduction: Resolving the "Vagus Myth"
Mapping the autonomic nervous system is technically challenging due to the tendency of retrograde tracers—substances that travel from nerve endings back to cell bodies—to leak from the target site. In previous studies of the renal plexus, researchers often observed labeled cells in the brain's vagus nerve nuclei, suggesting a direct parasympathetic connection to the kidney. However, these findings were inconsistent, leading many to suspect "pseudo-labeling" caused by tracer leakage into the surrounding body cavity. This study addresses this technical hurdle to definitively identify the origins of renal efferent nerves and determine if the parasympathetic nervous system is truly involved.
Methods and Anatomical Mapping
To eliminate tracer diffusion, a refined surgical technique was employed using a hermetically sealed microcapsule system. A tiny Teflon microtube was used to bundle the separated renal nerves, and the ends were sealed with surgical-grade cyanoacrylate glue. This closed environment was then filled with Fluoro-gold (FG), ensuring the tracer was only absorbed by the intended renal nerves.
Histological analysis was performed three days post-injection on 12 male Sprague-Dawley rats. Researchers examined prevertebral ganglia (Celiac, Aorticorenal, Suprarenal), bilateral sympathetic trunks (T9 to L2), the medulla oblongata (specifically the Dorsal Motor Nucleus of the Vagus, or DMV), and sacral spinal cord segments. A control group, where FG was applied outside a vacant capsule, was used to validate the seal's effectiveness.
Quantitative Distribution of Efferent Fibers
The study revealed that renal efferent innervation is almost exclusively sympathetic and highly localized. The primary "command centers" are concentrated in the T12 and T13 segments of the ipsilateral sympathetic trunk and the suprarenal ganglia (SrG).
Key findings include:
- Primary Origins: The majority of fibers originate in the ipsilateral sympathetic trunk at T12–T13 and the SrG (17.6 ± 3.1% of total labeled cells).
- Secondary Origins: Smaller populations were identified in the Celiac Ganglia (4.9%) and Aorticorenal Ganglia (4.6%).
- Asymmetry: Innervation is predominantly ipsilateral, with approximately 70.3% of labeled cells found on the same side as the injection.
- Absence of Parasympathetic Input: Crucially, no labeled cells were detected in the DMV or sacral cord segments. This strongly suggests that previous reports of vagal innervation were likely artifacts of tracer leakage.
Discussion: The Cholinergic Paradox and Future Directions
The total absence of vagal labeling raises questions about the kidney's known response to acetylcholine, a primary parasympathetic neurotransmitter. The authors suggest that these cholinergic effects might be "non-neuronal," perhaps mediated by local cells within the kidney's collecting ducts rather than direct brain-to-organ neural pathways.
While this study provides a definitive map of efferent fibers in rats, several areas remain for future inquiry. This research focused strictly on outgoing signals; the pathways for afferent (sensory) signals from the kidney require separate investigation. Additionally, while the rat is a standard model, autonomic architecture can vary between species, necessitating verification in larger mammals to generalize these findings to human physiology. Identifying the exact non-neuronal pathways for cholinergic signaling remains a key next step in understanding renal regulation.
Summary updated